HealthIT Answers April 16, 2024
The landscape of drug development is fraught with escalating costs and formidable challenges. Lengthy timelines, exorbitant expenses, and regulatory hurdles often impede progress, hindering the timely delivery of life-saving treatments to patients who need them. In this challenging context, the critical role of artificial intelligence (AI) in revolutionizing clinical trials cannot be overstated.
AI is heralding a new era in drug development, promising groundbreaking solutions to longstanding challenges. Traditional clinical trials are often plagued by manual processes, leading to prolonged timelines and soaring costs.
AI offers a solution by digitizing and automating data flow, significantly reducing the time and effort required for patient screening, enrollment, and clinical data management. By streamlining these processes, AI expedites drug development and lowers associated...
Today's Sponsors
Today's Sponsor